Follow-On Protein 505(b)(2) Applications Do Not Require Pharm/Tox Studies

Follow-on protein applications submitted under the 505(b)(2) mechanism do not require pharmacology/ toxicology studies, Office of Clinical Pharmacology & Biopharmaceutics Team Leader Hae-Young Ahn said Feb. 14